Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-01, Stock:JNJ, The news for the past five days is as follows:
2021-08-25: NEWS1: Alabama doctor explains COVID-19 situation in the South.NEWS2: Dow Jones Gains, S&P 500, Nasdaq Hit New Highs; These Stocks Rally On House Vote.NEWS3: J&J Covid Booster Generates 'Rapid And Robust' Antibody Response.NEWS4: Dow Jones Gains As Apple Falls; J&J Slips Despite Booster News; These Stocks Pass Buy Points.NEWS5: ‘I am in favor of companies adopting these strong policies about covid vaccination & mandating it’: Doctor.NEWS6: UPDATE 1-J&J says booster dose increased antibodies in early-stage trials.NEWS7: Delta's unvaccinated workers to pay extra $200 on health plan.NEWS8: Nasdaq Holds Gain; Here Are Some Winners From The Infrastructure Bill.NEWS9: 10 Best No-Fee DRIP Stocks to Buy Now.NEWS10: J&J’s latest booster shot news, Moderna pushes for FDA approval, Pentagon’s vaccine mandate.NEWS11: J&J Covid Booster Generates 'Rapid And Robust' Antibody Response.NEWS12: Nasdaq Pares Gains As Stock Advance Slows; This IBD 50 Stock Tops Buy Point.NEWS13: Moderna completes BLA submission for full approval of COVID-19 vaccine.NEWS14: J&J says an extra dose of its COVID-19 vaccine can boost antibody levels.NEWS15: J&J’s Covid Vaccine Booster Shot Increased Antibodies in Early Trials. What Comes Next..NEWS16: 2 Stocks to Help You Build Retirement Wealth.NEWS17: J&J says new data indicates an extra dose of its COVID-19 vaccine can boost antibody levels.NEWS18: Coronavirus tally: Daily average of COVID-19 cases rises to 7-month high, as J&J data supports booster shots.NEWS19: J&J says booster dose increased antibodies in early-stage studies.NEWS20: Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine.NEWS21: Nordstrom, Urban Outfitters Fall Premarket; Dick's Sporting Goods Rises.NEWS22: J&J Gains as Covid Booster Found to Trigger Strong Response.NEWS23: Johnson & Johnson Stock Gains After Promising COVID Booster Shot Data.
2021-08-26: NEWS1: /C O R R E C T I O N -- Johnson & Johnson/.NEWS2: J&J Defeats Effort to Block Texas Corporate Restructuring Move.NEWS3: U.S. judge declines to stop J&J from splitting talc liabilities from main business.NEWS4: Emergency medicine physician: Delta has 'changed the game' for COVID-19.NEWS5: UPDATE 3-U.S. judge declines to stop J&J from splitting talc liabilities from main business.NEWS6: COVID vaccine: Experts debate best timing for booster shots for America.NEWS7: Best practices on how to prove your Covid-19 vaccination status.NEWS8: The cost of being unvaccinated in the U.S..NEWS9: Delta variant surge: 'I wish everyone was mandated to have the vaccine,' says Alabama doctor.NEWS10: Sackler Immunity and a Texas Two-Step Could Tilt Bankruptcy Scales Away From Victims.NEWS11: Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs.NEWS12: J&J (JNJ) Reports Positive Interim Data on COVID Booster Jab.NEWS13: Moderna (MRNA) Seeks Full FDA Approval for COVID-19 Vaccine.NEWS14: U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January.NEWS15: Better Healthcare Stock: Johnson & Johnson vs. Pfizer.NEWS16: 3 Pharma Stocks to Buy With Juicy Dividends.
2021-08-27: NEWS1: SCAN Health Plan CEO on reducing Covid-19 vaccine disparities among minorities.NEWS2: US Judge Allows Johnson & Johnson To Split Talc Powder Liabilities Into New Company.NEWS3: NIH starts study of COVID-19 booster shot in people with autoimmune diseases.NEWS4: Pfizer (PFE) Inks Deal With Eurofarma to Make COVID-19 Vaccine.NEWS5: 3 Top-Quality Dividend Stocks for a Secure Retirement.NEWS6: Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster Data.NEWS7: The Challenges Vaccine Stocks Face As They Try To Fight Delta Variant.NEWS8: 7 Safe Stocks To Buy for an Increasingly Unstable World.
2021-08-30: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Doctor on booster shots: 'What we may be talking about is a vaccine that requires 3 shots'.NEWS3: Early polls & surveys show there’s about a 25% likelihood that parents are going to vaccinate their kids: Doctor.NEWS4: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS5: Scientists debate the need for booster shots.NEWS6: UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma.
2021-08-31: NEWS1: Doctor: Pediatric hospital units are 'getting stretched' due to Delta variant.NEWS2: 15 Best Pharmaceutical Stocks to Invest In.NEWS3: 5 Best Pharmaceutical Stocks to Invest In.NEWS4: Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict.NEWS5: J&J’s potential HIV vaccine falls short in sub-Saharan Africa trial.NEWS6: UPDATE 1-Nigeria prioritising four COVID-19 vaccines, not including Sinopharm.NEWS7: Unvaccinated Americans are ‘irresponsibly filling up our ERs and ICUs’: doctor.NEWS8: UPDATE 2-J&J's HIV vaccine fails trial in latest blow to the field.NEWS9: Johnson & Johnson's HIV vaccine fails mid-stage study in Africa.NEWS10: Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa.NEWS11: Johnson & Johnson HIV Vaccine Candidate Fails Mid-Stage Trial.

Answer: Rise